Melanoma: from mutations to medicine
Hensin Tsao(Boston University), David E. Fisher(Massachusetts General Hospital)
Cited by 476
Related Papers
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
|Nature|2005|1.5k
BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
|Clinical Cancer Research|2013|938
Guidelines of care for the management of primary cutaneous melanoma
|Journal of the American Academy of Dermatology|2018|707
Imatinib for Melanomas Harboring Mutationally Activated or Amplified <i>KIT</i> Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
|Journal of Clinical Oncology|2013|594
c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi
|Genes & Development|2000|517